Jump to content

Meta-DOB

From Wikipedia, the free encyclopedia
Meta-DOB
Clinical data
Other names5-Bromo-2,4-dimethoxyamphetamine; 2,4-Dimethoxy-5-bromoamphetamine
Routes of
administration
Oral[1]
ATC code
  • None
Pharmacokinetic data
Duration of action5–6 hours[1]
Identifiers
  • 1-(5-bromo-2,4-dimethoxyphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H16BrNO2
Molar mass274.158 g·mol−1
3D model (JSmol)
  • Brc1cc(c(OC)cc1OC)CC(N)C
  • InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-9(12)11(15-3)6-10(8)14-2/h5-7H,4,13H2,1-3H3 checkY
  • Key:YFSLPSITQIUFQK-UHFFFAOYSA-N checkY
  (verify)

Meta-DOB, or 5-bromo-2,4-dimethoxyamphetamine, is a drug.[1] It is similar in structure to DOB.[1] Meta-DOB was first synthesized by Alexander Shulgin.[1] In his book PiHKAL (Phenethylamines i Have Known And Loved), the dose range is listed as 50–100 mg, and the duration listed as 5–6 hours.[1] Meta-DOB produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of Meta-DOB.[1]

See also

[edit]

References

[edit]
  1. ^ a b c d e f g h Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
[edit]